[CUV] YoY Quarter Result on 30-Jun-2024 [#Q4]

Stock
[CUV] Clinuvel Pharmaceuticals Limited
Announcement Date
28-Jun-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q4]
Profit Trend
QoQ- 125.86%
YoY- 28.53%
Quarter Report
CUV's Result
CUV's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 55,376 48,966 41,091 32,232 22,594 22,066 18,416 20.11%
PBT 35,873 30,979 25,595 19,902 12,077 14,039 11,531 20.80%
Tax 11,173 11,762 10,587 1,661 -3,510 -19 282 84.53%
NP 24,700 19,217 15,008 18,241 15,588 14,059 11,782 13.11%
Tax Rate -31.15% -37.97% -41.36% -8.35% 29.07% 0.14% -2.44% -
Total Cost 30,676 29,749 26,083 13,991 7,007 8,008 6,634 29.04%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 44.60 39.25 36.52 56.59 68.99 63.71 63.98 -5.83%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.49 0.39 0.30 0.37 0.32 0.29 0.25 11.85%
EPS Diluted 0.49 0.37 0.29 0.36 0.31 0.28 0.25 11.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.